Company: NCEL
Filing Date: 2025-09-10
Form Type: 424B3
Source: 0001213900-25-086600
Chunk: 91

Company: NewcelX Ltd.
Filing Date: 2025-09-10
Form: 424B3
Chunk 91
---
 Merger Consideration will be less than the target 85% of all issued and outstanding shares. NLS will provide the final Exchange Ratio and Merger Consideration at the NLS Meeting. Under the Merger Agreement, any shareholder receiving NLS Common Shares in excess of a 9.99% beneficial ownership limitation as a result of the Merger, shall be issued instead pre -fundedwarrants exercisable for a number of NLS Common Shares equal to such NLS Common Shares in excess of the beneficial ownership limitation, at an exercise price equal to the par value of the NLS Common Shares as of the Effective Time, which, in any event, shall be no less than CHF 0.0001 per share. 3 Expected Timing of the Merger (Page 161) The Closing is expected to take place (i) no later than the second business day following the satisfaction or waiver of the conditions described below under the section titled “ Conditions to the Consummation of the Merger” on page 159 of this proxy statement/prospectus, or (ii) on such other date as agreed to by the parties to the Merger Agreement in writing, in each case, subject to the satisfaction or waiver of the closing conditions. The Merger Agreement may be terminated by NLS and/or Kadimastem if the Closing has not occurred by October31, 2025. NLS and Kadimastem anticipate that the consummation of the Merger will occur in the third quarter of 2025. However, because the Merger is subject to a number of conditions, neither NLS nor Kadimastem can predict exactly when the Closing will occur or if it will occur at all. For a description of the conditions to the completion of the Merger, see the section titled “ Conditions to the Consummation of the Merger” on page 159 of this proxy statement/prospectus. NLS Meeting (Page 104) Date, Time and Place of the of the NLS Meeting The NLS Meeting will be held at 4:00 pm, local time, on September29, 2025, at the premises of Baker McKenzie Switzerland AG, Holbeinstrasse30, 8034 Zurich, Switzerland. NLS will be hosting the NLS Meeting in person to consider and vote upon: •Proposal No. 1 to approve the Merger Agreement. •Proposal No. 2 to approve the par value reduction, reverse split and ordinary share capital increase with contribution of